Stocks · News reference

Mangoceuticals (MGRX) Shares Fall 12% After Hours: Here's Why

Oct 2, 2026, 5:22 AMTanya Rawat

Mangoceuticals shares fall 12% after hours despite a $2.5 million strategic investment in its antiviral IP subsidiary.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

BenzingaOct 9, 2026, 8:03 PMBenzinga Newsdesk
Mangoceuticals Closes Registered Direct Offering Following $2.5M Strategic Investment Commitment In MangoRx IP Holdings To Support Intellectual Property Commercialization
Transaction follows a $2.5 million strategic investment commitment at MangoRx IP Holdings to support intellectual property commercializationDALLAS, TX, Oct. 09, 2026 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc.
MGRX
SEC EDGAROct 9, 2026, 8:01 PMSEC EDGAR
8-K filing — MANGOCEUTICALS, INC. (MGRX)
Filed: 2026-10-09 AccNo: 0001493152-26-046510 Size: 698 KB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits
MGRX
BenzingaOct 2, 2026, 12:02 PMAvi Kapoor
Nike Posts Mixed Q1 Results, Joins Mangoceuticals And Other Big Stocks Moving Lower In Friday’s Pre-Market Session
U.S. stock futures rose, while Nike plunged 9.5% after missing revenue estimates. Roze AI, Mangoceuticals and other stocks also fell premarket.
AAPG EFX EIX FICO LNG
BenzingaOct 2, 2026, 9:56 AMRishabh Mishra
Stock Market Today: S&P 500, Dow Jones Futures Gain as September Jobs Report Misses Expectations— Nike, Synaptics, Corteva in Focus (UPDATED)
U.S. stock futures advanced on Friday, as the Dow Jones, S&P 500 and Nasdaq 100 indices rose, following Thursday's higher close.
BTCUSD CTVA MGRX NKE ON